It covers doses up to 50 units with 1-unit precision, which is more than sufficient for most protocols
The first dual GIP/GLP-1 receptor agonist, NNC0090-2746 (also known as RG7697, RO6811135, or MAR709), is a 40-amino acid peptide acylated with a C16:0 fatty acid to lysine residue at position 40 [ Figure 2 , Table 1 ]
Several dose levels have been explored as part of these studies: 1mg, 4mg, 8mg
What monitoring will be required
Independent testing helps confirm purity, identity, and the absence of harmful contaminants giving buyers greater confidence in what they are receiving
Overall, current research suggests that both retatrutide and liraglutide are effective at lowering HbA1c levels and are generally well-tolerated